Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1L - Antineoplastic and immunomodulating agents----[1] 85
2L 44----[1] 96
3L acetyl carnitine[1] Levocarnitine[3] D02030 ,
D02176 ,
D04713
--[1] 13
4L-000124467----[2] 13, 46
5L-000124467 (freebase)----[1] 46
6L-000124467-009J (succinat----[1] 46
7L-000883191----[1] 46
8L-001069957----[1] 46
9L-123 Ioflupane----[1] 6
10L-3-(3,4-Dihydroxyphenyl)alanine[1] Alanine[1] D00012 --[1] 6
11L-883191----[1] 46
12L-alanine[1] Alanine[1] D00012 --[1] 299
13L-Arg[1] Arginine[1] D02982 --[1] 78
14L-ARG+GHRH[2] Arginine,
Somatorelin
[2] D02982 ,
D08523
[1] GHRHR 💬[2] Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 💬[1] 78
15L-Arginin[1] Arginine[1] D02982 --[1] 65
16L-Arginin-hydrochlorid-einmolar Fresenius[1] Arginine[1] D02982 --[1] 65
17L-arginine[1] Arginine[1] D02982 --[3] 46, 113, 299
18L-asparaginase[1] Asparaginase Escherichia coli[1] D02997 --[1] 65
19L-Carnitine[1] Levocarnitine[3] D02030 ,
D02176 ,
D04713
--[7] 13, 86, 96, 97, 265, 298, 316
20L-Citrulline and Metformin & L-Citrulline[2] Citrulline,
Metformin
[3] D00944 ,
D04966 ,
D07706
[2] PRKAA1,
PRKAA2 💬
[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[1] 113
21L-Citrulline Malate[1] Citrulline[1] D07706 --[1] 86
22L-CsA----[1] 228
23L-DOPA[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
24L-Dopa/ MODOPAR[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
25L-DOPA/DDCI[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
26L-DOPS[1] Droxidopa[1] D01277 [9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 6
27L-fucose[1] Fucose---[1] 65
28L-Glutamine[1] L-Glutamine[1] D00015 --[2] 113, 299
29L-Histidine[1] Histidine[1] D00032 --[1] 13
30L-Lactic acid[2] L-Lactic acid,
Lactic acid
[1] D00111 --[1] 265
31L-leucine[1] Leucine[1] D00030 --[1] 284
32L-Lysine N acetylcysteinate[1] Lysine[1] D02304 --[1] 299
33L-Lysine N-acetylcysteinate[1] Lysine[1] D02304 --[1] 299
34L-Lysine- N-acetylcysteinate[1] Lysine[1] D02304 --[1] 299
35L-Lysine-N-acetyl-L-cysteinate[1] Lysine[1] D02304 --[1] 299
36L-Lysine-N-acetylcysteinate[1] Lysine[1] D02304 --[1] 299
37L-Lysyl-D-Prolyl-L-Threonine Acetate[2] Acetate,
Threonine
[1] D00041 --[1] 97
38L-Lysyl-D-Prolyl-LThreonine acetate, lyophilisate[1] Acetate---[1] 97
39L-methionine[1] Methionine[2] D00019 ,
D04983
--[1] 84
40L-METHIONINE ([11C]METHYL)[1] Methionine[2] D00019 ,
D04983
--[1] 84
41L-methylfolate[1] Levomefolic acid[1] D09353 --[1] 6
42L-Serine[1] Serine[1] D00016 --[1] 2
43L-Threo DOPS[1] Droxidopa[1] D01277 [9] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3 💬
[14] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 17
44L-tyrosine[1] Tyrosine[1] D00022 --[2] 6, 111
45L0006CP03A----[1] 75
46L01 - Antineoplastic agents----[1] 85
47L0122----[1] 279
48L0133----[1] 50
49L01AA03----[1] 28
50L01BA----[1] 96
51L01BA01----[2] 46, 107
52L01BB04----[1] 13
53L01X - Other antineoplastic agents----[1] 85
54L01X CO2----[1] 46
55L01XC02----[1] 46
56L01XC15----[1] 222
57L01XE - Protein kinase inhibitors----[1] 85
58L01XE31 - Nintedanib[1] Nintedanib[1] D10481 [8] FGFR1,
FGFR2,
FGFR3,
FLT1,
FLT4,
KDR,
PDGFRA,
PDGFRB 💬
[34] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, EGFR tyrosine kinase inhibitor resistance, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬[1] 85
59L01XX14----[1] 75
60L03 AB----[1] 13
61L03 AB 08----[1] 13
62L03 AB07----[1] 13
63L03AB13----[1] 13
64L04 AB04----[1] 46
65L04041)----[1] 46
66L04AA04 - IMMUNOGLOBULINA ANTITIMOCITARIA (DI CONIGLIO) IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI THYMOGLOBULINE[1] Antithymocyte immunoglobulin (rabbit)---[1] 13
67L04AA10----[2] 278, 280
68L04AA11----[1] 46
69L04AA18----[1] 158
70L04AA24----[2] 46, 271
71L04AA25----[1] 62
72L04AA26----[1] 49
73L04AA31----[1] 13
74L04AB01----[2] 46, 271
75L04AB04----[4] 46, 107, 160, 271
76L04AB05----[2] 46, 271
77L04AC06----[2] 44, 45
78L04AC07----[1] 46
79L04AX03----[1] 46
80L606 (Liposomal Treprostinil) Inhalation Solution 51ug[1] Treprostinil[1] D06213 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
81L606 Inhalation System----[1] 86
82LA----[5] 6, 13, 75, 76, 222
83LA294----[1] 49
84LABA/LAMA----[1] 299
85LABP-104 250mg----[1] 49
86Lacosamide[1] Lacosamide[1] D07299 [2] SCN3A,
SCN9A 💬
[1] Taste transduction 💬[3] 2, 46, 149
87Lacryvisc[1] Carbomer---[1] 53
88Lactated Ringer----[1] 296
89Lactated Ringers----[2] 96, 97
90Lactic acid[1] Lactic acid[1] D00111 --[2] 265, 299
91Lactic acid producing organisms[1] Lactic acid[1] D00111 --[1] 299
92Lactizole nebulization----[1] 299
93Lactobacillus[1] Lactobacillus delbrueckii bulgaricus---[5] 6, 46, 51, 97, 299
94Lactobacillus casei[1] Lactobacillus casei[1] D04351 --[3] 6, 97, 296
95Lactobacillus casei DG[1] Lactobacillus casei[1] D04351 --[1] 97
96Lactobacillus casei DG (Enterolactis duo®)[1] Lactobacillus casei[1] D04351 --[1] 6
97Lactobacillus casei rhamnosus (Lcr35)[1] Lactobacillus casei[1] D04351 --[1] 296
98Lactobacillus GG[1] Lactobacillus delbrueckii bulgaricus---[1] 97
99Lactobacillus plantarum[1] Lactobacillus plantarum---[3] 6, 97, 156
100Lactobacillus plantarum PS128[1] Lactobacillus plantarum---[1] 6
101LACTOBACILLUS REUTERI[1] Lactobacillus reuteri---[2] 97, 299
102Lactobacillus rhamnosus[1] Lactobacillus delbrueckii bulgaricus---[1] 299
103Lactobacillus rhamnosus GG[1] Lactobacillus delbrueckii bulgaricus---[1] 299
104Lactobacillus rhamnosus GG ATCC 53103[1] Lactobacillus delbrueckii bulgaricus---[1] 97
105Lactobacillus salivarius[1] Lactobacillus salivarius---[2] 96, 97
106Lactobacillus salivarius UCC118[1] Lactobacillus salivarius---[2] 96, 97
107Lactobacilus acidophilus & bifidobacterium animalis/lactis[1] Lactobacillus acidophilus[1] D04349 --[1] 97
108Lactose[1] Lactose[2] D00046 ,
D03226
--[6] 2, 6, 13, 97, 228, 310
109Lactose in water[2] Lactose,
Water
[3] D00001 ,
D00046 ,
D03226
--[1] 97
110Lactose monohydrate[1] Lactose[2] D00046 ,
D03226
--[1] 13
111Lactulose[1] Lactulose[1] D00352 --[3] 13, 96, 291
112Lactulose/Rhamnose solution[2] Lactulose,
Rhamnose
[1] D00352 --[1] 96
113Ladarixin[1] Ladarixin---[1] 162
114Lademirsen----[1] 218
115Lademirsen (SAR339375)----[1] 218
116LADICell----[1] 65
117LAM-002A----[1] 2
118LAMAZYM[1] Velmanase alfa[1] D11024 [1] MAN2B1 💬[2] Lysosome, Other glycan degradation 💬[1] 19
119Lamictal[1] Lamotrigine[1] D00354 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 144
120Lamivudine[1] Lamivudine[1] D00353 --[7] 2, 26, 42, 46, 135, 265, 325
121Lamivudine (3TC)[1] Lamivudine[1] D00353 --[1] 325
122Lamivudine/Zidovudine[2] Lamivudine,
Zidovudine
[2] D00353 ,
D00413
--[1] 265
123Lamotrigin----[2] 34, 195
124Lamotrigin actavis----[1] 114
125Lamotrigin beta----[2] 34, 195
126Lamotrigin ”Nordic Prime 100 mg----[1] 114
127Lamotrigin ”Nordic Prime 25 mg----[1] 114
128Lamotrigin ”Nordic Prime 50 mg----[1] 114
129Lamotrigine[1] Lamotrigine[1] D00354 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[5] 13, 34, 38, 114, 144
130Lamotrigine - generic product[1] Lamotrigine[1] D00354 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 38
131Lamotrigine 25Mg Oral Tablet, Extended Release[1] Lamotrigine[1] D00354 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 114
132Lamotrigine dispers[1] Lamotrigine[1] D00354 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 34
133Lamotrigine extended release tablets[1] Lamotrigine[1] D00354 [5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 13
134Land exercises----[1] 46
135LANIFIBRANOR[1] Lanifibranor---[1] 51
136Lannacher----[1] 298
137Lanraplenib[1] Lanraplenib[1] D11596 --[2] 53, 222
138Lanreotide[1] Lanreotide---[4] 67, 73, 85, 298
139LANREOTIDE ACETATE[2] Acetate,
Lanreotide
---[4] 67, 73, 85, 298
140Lansolprazole----[1] 166
141Lansoprazole[1] Lansoprazole[1] D00355 [2] ATP4A,
ATP4B 💬
[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[7] 63, 71, 85, 98, 166, 222, 299
142Lansoprazole 30mg[1] Lansoprazole[1] D00355 [2] ATP4A,
ATP4B 💬
[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 166
143Lansoprazole, amoxicillin, clarithromycin[3] Amoxicillin,
Clarithromycin,
Lansoprazole
[5] D00229 ,
D00276 ,
D00355 ,
D02925 ,
D07452
[2] ATP4A,
ATP4B 💬
[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 222
144Lansoprazole, clarithromycin, amoxycillin[3] Amoxicillin,
Clarithromycin,
Lansoprazole
[5] D00229 ,
D00276 ,
D00355 ,
D02925 ,
D07452
[2] ATP4A,
ATP4B 💬
[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 63
145Lantarel----[1] 46
146Lantus 100 units/ml solution for injection in a cartridge----[1] 299
147LANTUS*SC 5CAR3ML100UI/ML[1] Insulin glargine[1] D03250 [1] INSR 💬[22] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 299
148Lantus® 100 Units/ml solution for injection in a vial. Lantus® 100 Units/ml solution for injection in a cartridge. Lantus® 100 Units/ml solution for injection in a pre-filled pen----[1] 299
149Lap TAP Bupivacaine/Epinephrine[2] Bupivacaine,
Epinephrine
[5] D00095 ,
D00996 ,
D01450 ,
D02149 ,
D07552
[14] ADRA1A,
ADRA1B,
ADRA1D,
ADRA2A,
ADRA2B,
ADRA2C,
ADRB1,
ADRB2,
ADRB3,
SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[16] AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 96
150Lapaquistat[1] Lapaquistat---[1] 79
151Lapaquistat acetate and current lipid-lowering treatment[2] Acetate,
Lapaquistat
---[1] 79
152Lapatinib[1] Lapatinib[2] D04024 ,
D08108
[2] EGFR,
ERBB2 💬
[50] Adherens junction, Bladder cancer, Breast cancer, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease - COVID-19, Cushing syndrome, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Platinum drug resistance, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Tight junction 💬[3] 34, 74, 75
153Lapine T-Lymphocyte Immune Globulin[1] Antithymocyte immunoglobulin (rabbit)---[4] 62, 65, 283, 286
154LAQUINIMOD[1] Laquinimod---[4] 8, 13, 49, 96
155Laquinimod 0.3[1] Laquinimod---[1] 13
156Laquinimod 0.6[1] Laquinimod---[1] 13
157Laquinimod 1.2[1] Laquinimod---[1] 13
158Laquinimod Capsulas 0.6 mg[1] Laquinimod---[1] 13
159Laquinimod Capsules 0.3 mg[1] Laquinimod---[1] 13
160Laquinimod capsules 0.5 mg[1] Laquinimod---[2] 8, 96
161Laquinimod Capsules 0.6 mg[1] Laquinimod---[1] 13
162Laquinimod Cápsulas 0.5 mg[1] Laquinimod---[1] 96
163Laquinimod Sodium (USAN)[1] Laquinimod---[1] 13
164Laquinimod Tablets 0.3 mg[1] Laquinimod---[1] 13
165Large bore (19G) histologic needle biopsy of the mediastinal lymph nodes----[1] 84
166Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP[5] Dapsone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone,
Triamcinolone
[18] D00385 ,
D00472 ,
D00592 ,
D00752 ,
D00980 ,
D00981 ,
D00982 ,
D00983 ,
D00984 ,
D00985 ,
D01239 ,
D01998 ,
D02156 ,
D03301 ,
D05094 ,
D05095 ,
D05096 ,
D06216
[3] IMPDH1,
IMPDH2,
NR3C1 💬
[4] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬[1] 162
167Large Neutral Amino Acid Therapy----[1] 240
168Large protein molecule----[1] 46
169Lariam[1] Mefloquine[1] D04895 --[1] 25
170LARONIDASE[1] Laronidase[1] D04670 [1] IDUA 💬[3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬[2] 19, 256
171Laronidase ERT[1] Laronidase[1] D04670 [1] IDUA 💬[3] Glycosaminoglycan degradation, Lysosome, Metabolic pathways 💬[1] 19
172Lateral transperitoneal LA----[1] 75
173Latozinemab----[1] 127
174Latrepirdine[1] Latrepirdine[1] D09917 [6] ACHE,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬
[22] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Glycerophospholipid metabolism, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬[1] 8
175LAU-7b----[1] 299
176LAX-101[1] LAX-101---[1] 8
177LB-P6----[1] 46
178LB-P8----[1] 46
179LB03002----[1] 78
180LBAL----[1] 46
181LBEC0101----[1] 46
182LC51-0255----[1] 97
183LCI699----[1] 75
184LCI699, 1 mg----[1] 75
185LCI699, 10 mg----[1] 75
186LCI699, 20 mg----[1] 75
187LCI699, 5 mg----[1] 75
188LCIG----[1] 6
189LCIG (Duodopa)----[1] 6
190LCP-Tacro (tacrolimus)[1] Tacrolimus[2] D00107 ,
D08556
[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 95
191LCZ696----[1] 58
192LCZ696 100 mg----[1] 58
193LCZ696 200 mg----[1] 58
194LCZ696 50 mg----[1] 58
195LD / BE----[1] 6
196LD+DDCI----[1] 6
197LD-aminopterin[1] Aminopterin---[1] 46
198LD-DDCI----[1] 6
199LD/CD----[1] 6
200LDP-02----[2] 96, 97
201LDT----[1] 65
202LEBRIKIZUMAB[1] Lebrikizumab[1] D09633 [1] IL13 💬[8] Asthma, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, IL-17 signaling pathway, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation 💬[1] 85
203Lederspan----[1] 107
204Ledertrexate----[1] 46
205Ledertrexato----[1] 46
206Ledipasvir[1] Ledipasvir[1] D10442 --[1] 19
207Ledipasvir/Sofosbuvir[2] Ledipasvir,
Sofosbuvir
[2] D10366 ,
D10442
--[1] 19
208Lefamulin[1] Lefamulin[1] D11631 --[1] 299
209Leflunomide[1] Leflunomide[1] D00749 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[12] 11, 40, 46, 49, 53, 66, 107, 162, 224, 270, 271, 300
210Leflunomide (permitted, not necessary)[1] Leflunomide[1] D00749 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 46
211Leflunomide 10 milligram (MG)[1] Leflunomide[1] D00749 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 46
212Leflunomide 10mg Tab[1] Leflunomide[1] D00749 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 40
213Leflunomide 20 mg Tablets (Geneva Pharmaceutical)[1] Leflunomide[1] D00749 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 46
214Leflunomide 20 mg+prednisone 0.5mg/kg/d[2] Leflunomide,
Prednisone
[2] D00473 ,
D00749
[2] DHODH,
NR3C1 💬
[4] Biosynthesis of cofactors, Metabolic pathways, Neuroactive ligand-receptor interaction, Pyrimidine metabolism 💬[1] 66
215Leflunomide 20Mg Tab[1] Leflunomide[1] D00749 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 46
216Leflunomide 20mg/d[1] Leflunomide[1] D00749 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 53
217Leflunomide Mylan[1] Leflunomide[1] D00749 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 53
218Leflunomide(LEF)[1] Leflunomide[1] D00749 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 224
219Leflunomide-Sulfasalazine-Hydroxychloroquine[3] Hydroxychloroquine,
Leflunomide,
Sulfasalazine
[3] D00448 ,
D00749 ,
D08050
[1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 46
220Leflunomidum[1] Leflunomide[1] D00749 [1] DHODH 💬[3] Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 💬[1] 46
221Left ventricular contractile reserve SE----[3] 58, 86, 215
222Left ventricular outflow tract gradient SE----[3] 58, 86, 215
223Lemtrada[1] Alemtuzumab[1] D02802 [1] CD52 💬-[2] 13, 65
224LEMTRADA 12 mg Konzentrat zur Herstellung einer Infusionslösung[1] Alemtuzumab[1] D02802 [1] CD52 💬-[1] 13
225Lenabasum----[3] 50, 51, 299
226Lenabasum 20 mg----[3] 50, 51, 299
227Lenabasum 20 mg Powder in Capsule----[1] 51
228Lenabasum 5 mg----[3] 50, 51, 299
229Lenabasum 5 mg Powder in Capsule----[1] 51
230Lenabasum 5mg Powder in Capsule----[1] 51
231Lenadogene nolparvovec----[1] 302
232Lenalidomide[1] Lenalidomide[1] D04687 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[8] 16, 26, 28, 34, 49, 284, 300, 331
233Lenalidomide 25mg[1] Lenalidomide[1] D04687 [1] TNF 💬[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28
234Lenalidomide and dexamethasone[2] Dexamethasone,
Lenalidomide
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D04687
[2] NR3C1,
TNF 💬
[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16
235Lenalidomide+Dexamethasone[2] Dexamethasone,
Lenalidomide
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D04687
[2] NR3C1,
TNF 💬
[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16
236Lenalidomide, Dexamethasone[2] Dexamethasone,
Lenalidomide
[10] D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D04687
[2] NR3C1,
TNF 💬
[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 16
237Lenalidomide, Dexamethasone and Cyclophosphamide[3] Cyclophosphamide,
Dexamethasone,
Lenalidomide
[12] D00287 ,
D00292 ,
D00975 ,
D01510 ,
D01615 ,
D01632 ,
D01948 ,
D02174 ,
D02591 ,
D02592 ,
D04687 ,
D07760
[2] NR3C1,
TNF 💬
[68] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 28
238Leniolisib[1] Leniolisib[1] D11158 [3] PIK3CA,
PIK3CB,
PIK3CD 💬
[106] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Acute myeloid leukemia, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Amoebiasis, Apoptosis, Autophagy - animal, Axon guidance, B cell receptor signaling pathway, Bacterial invasion of epithelial cells, Breast cancer, C-type lectin receptor signaling pathway, Carbohydrate digestion and absorption, Cellular senescence, Central carbon metabolism in cancer, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Colorectal cancer, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endometrial cancer, Epstein-Barr virus infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, FoxO signaling pathway, Gastric cancer, Glioma, GnRH secretion, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory mediator regulation of TRP channels, Influenza A, Inositol phosphate metabolism, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Longevity regulating pathway, Longevity regulating pathway - multiple species, Measles, Melanoma, Metabolic pathways, MicroRNAs in cancer, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Phosphatidylinositol signaling system, Phospholipase D signaling pathway, Platelet activation, Platinum drug resistance, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Renal cell carcinoma, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Small cell lung cancer, Sphingolipid signaling pathway, Spinocerebellar ataxia, T cell receptor signaling pathway, TNF signaling pathway, Thyroid hormone signaling pathway, Toll-like receptor signaling pathway, Type II diabetes mellitus, VEGF signaling pathway, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway, mTOR signaling pathway 💬[2] 53, 65
239Lenogastrim----[1] 28
240Lenograstim[1] Lenograstim[1] D03247 [1] CSF3R 💬[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬[7] 2, 13, 16, 18, 19, 57, 65
241Lenti-D Drug Product----[1] 20
242Lentiviral G1XCGD Gene Therapy----[1] 65
243Lentiviral vector containing ABCA4 gene----[1] 301
244Lentiviral vector containing MYO7A gene----[2] 90, 303
245Lentiviral vector containing the human MY07A gene----[2] 90, 303
246Lentiviral Vector Trans-Skip gene modified Autologous Mesoangioblasts----[1] 113
247Lentiviral vector transduced CD34+ cells----[1] 65
248Lentivirus Alpha-gal A transduced stem cells----[1] 19
249Lentivirus-mediated delivery of ARSA to the CNS.----[1] 19
250Lenzumestrocel----[1] 2
251Leptin[1] Leptin---[2] 6, 265
252Leriglitazone[1] Leriglitazone[1] D11603 [1] PPARG 💬[11] AMPK signaling pathway, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[1] 20
253Lerodalcibep----[1] 79
254Letairis[1] Ambrisentan[1] D07077 [1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 85
255Letairis 10 mg[1] Ambrisentan[1] D07077 [1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 85
256Letairis 5 mg[1] Ambrisentan[1] D07077 [1] EDNRA 💬[7] Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 85
257Letermovir[1] Letermovir[1] D10801 --[1] 85
258Letrozole[1] Letrozole[1] D00964 [1] CYP19A1 💬[3] Metabolic pathways, Ovarian steroidogenesis, Steroid hormone biosynthesis 💬[2] 81, 89
259Leucine[1] Leucine[1] D00030 --[11] 5, 6, 7, 19, 65, 96, 97, 127, 283, 284, 299
260Leuco-methylthioninium bis(hydromethanesulfonate)[1] Methylthioninium---[1] 127
261Leucovorin[1] Leucovorin[3] D01211 ,
D07986 ,
D07987
--[2] 19, 46
262Leukapheresis----[5] 49, 51, 96, 284, 285
263Leukine[1] Sargramostim[1] D05803 [1] CSF2RA 💬[4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 229
264Leukopheresis----[1] 51
265Leuplin----[1] 76
266Leuplin DPS 11.25mg----[1] 76
267Leuprolide[1] Leuprolide[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[5] 1, 2, 3, 51, 76
268Leuprolide (GnRH agonists)[2] Gonadorelin,
Leuprolide
[5] D00988 ,
D00989 ,
D03267 ,
D04361 ,
D08027
[1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 76
269Leuprolide Acetate (LA)[2] Acetate,
Leuprolide
[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 76
270Leuprolide acetate 11.25 mg[2] Acetate,
Leuprolide
[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 76
271Leuprolide Acetate 3 Month Depot[2] Acetate,
Leuprolide
[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 76
272Leuprolide acetate 30 mg[2] Acetate,
Leuprolide
[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 76
273Leuprolide Acetate 45 mg[2] Acetate,
Leuprolide
[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 76
274Leuprolide acetate depot[2] Acetate,
Leuprolide
[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 76
275Leuprorelin[1] Leuprolide[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[2] 1, 76
276Leuprorelin Acetate[2] Acetate,
Leuprolide
[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[2] 1, 76
277Leuprorelin Acetate 3.75mg Injection[2] Acetate,
Leuprolide
[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 76
278Levact----[1] 61
279Levamisole[1] Levamisole[2] D00750 ,
D08114
--[3] 60, 61, 62
280Levamisole hydrochloride[1] Levamisole[2] D00750 ,
D08114
--[1] 60
281Levamisole+cyclosporin A+Glucocorticoids[2] Cyclosporine,
Levamisole
[3] D00184 ,
D00750 ,
D08114
[5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[2] 60, 62
282Levaquin----[1] 84
283Levemir[1] Insulin detemir[1] D04539 [1] INSR 💬[22] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 299
284Levemir 100 U/ml solution for injection in a cartridge, Levemir 100 U/ml solution for injection in a pre-filled pen[1] Insulin detemir[1] D04539 [1] INSR 💬[22] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 299
285Levemir FlexPen[1] Insulin detemir[1] D04539 [1] INSR 💬[22] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 299
286Levemir insulin[1] Insulin detemir[1] D04539 [1] INSR 💬[22] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 299
287Levemir Penfill[1] Insulin detemir[1] D04539 [1] INSR 💬[22] AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway 💬[1] 299
288Levetiracetam[1] Levetiracetam[1] D00709 [1] SV2A 💬[1] ECM-receptor interaction 💬[5] 2, 4, 6, 13, 307
289Levitra[1] Vardenafil[3] D02731 ,
D03260 ,
D08668
[1] PDE5A 💬[3] Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬[2] 13, 86
290Levobupivacaine[1] Levobupivacaine[2] D01287 ,
D08116
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 46
291Levocarnil----[1] 13
292LEVOCARNITINE[1] Levocarnitine[3] D02030 ,
D02176 ,
D04713
--[3] 3, 53, 97
293Levocarnitine propyl hydrochloride[1] Levocarnitine[3] D02030 ,
D02176 ,
D04713
--[1] 97
294Levocetirizina[1] Levocetirizine[1] D07402 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 61
295LEVOCETIRIZINA DICLORIDRATO[1] Levocetirizine[1] D07402 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 61
296Levocitirizina----[1] 61
297Levodopa[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[8] 2, 4, 6, 17, 90, 140, 164, 201
298LEVODOPA (DC.IT) (FU)[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
299Levodopa (delivered intravenously)[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
300Levodopa (drug), intraduodenal administration[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
301Levodopa (L-dopa)[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
302Levodopa (L-DOPA) + Standard care[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
303LEVODOPA (LD)[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
304Levodopa / Benserazid[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
305LEVODOPA / BENSERAZIDE 200 + 50 MG[2] Benserazide,
Levodopa
[2] D00059 ,
D03082
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
306Levodopa 100 mg / benserazide 25 mg[2] Benserazide,
Levodopa
[2] D00059 ,
D03082
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
307Levodopa 100 mg A CAP[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
308Levodopa 125 mg A CAP[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
309Levodopa 150 mg A CAP[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
310Levodopa 25mg/100mg[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
311Levodopa 75 mg A CAP[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
312Levodopa acute challenge[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
313Levodopa and carbidopa[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
314Levodopa and carbidopa SC solution[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
315Levodopa and carbidopa solution for SC administration[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
316Levodopa and decarboxylase inhibitor[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
317Levodopa and Domperidone[2] Domperidone,
Levodopa
[3] D00059 ,
D01745 ,
D07868
[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
318Levodopa Benserazide Madopar[2] Benserazide,
Levodopa
[2] D00059 ,
D03082
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
319Levodopa Benserazide Teva Italia[2] Benserazide,
Levodopa
[2] D00059 ,
D03082
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
320Levodopa carbidopa (LC) oral encapsulated immediate release (IR) tablets[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
321Levodopa carbidopa intestinal gel (LCIG)[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
322Levodopa CR (controlled release)[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
323Levodopa Cyclops[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
324LEVODOPA DC.IT FU[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
325Levodopa dispersible[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
326Levodopa infusion[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
327LEVODOPA INN[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
328Levodopa MR[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
329Levodopa powder for inhalation[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
330Levodopa tablet[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
331Levodopa test[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 17
332Levodopa, carbidopa, entacapone[3] Carbidopa,
Entacapone,
Levodopa
[3] D00059 ,
D00558 ,
D00781
[7] COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
333Levodopa, carbidopa, ODM-104[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
334Levodopa, decarboxylase inhibitor and COMT inhibitor[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
335Levodopa-4'-Monophosphate[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
336Levodopa-Carbidopa[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[2] 6, 90
337Levodopa-carbidopa (LC) oral encapsulated immediate release (IR) tablets[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
338Levodopa-carbidopa Immediate Release (LC-IR) Tablets[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
339Levodopa-Carbidopa Intestinal Gel[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
340Levodopa-Carbidopa Intestinal Gel (LCIG)[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
341Levodopa-Carbidopa Multilayer Extended Release Tablet[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
342Levodopa-Carbidopa XL tablet (M)[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
343Levodopa-carbidopa-entacapone[3] Carbidopa,
Entacapone,
Levodopa
[3] D00059 ,
D00558 ,
D00781
[7] COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
344Levodopa/benserazide[2] Benserazide,
Levodopa
[2] D00059 ,
D03082
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
345Levodopa/benserazide 100/25 mg[2] Benserazide,
Levodopa
[2] D00059 ,
D03082
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
346LEVODOPA/BENZERASIDE[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
347Levodopa/Benzerazide[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
348LEVODOPA/CARBIDOPA[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[2] 6, 164
349Levodopa/Carbidopa (4:1)[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 201
350Levodopa/Carbidopa (LD/CD)[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
351Levodopa/Carbidopa (Sinemet)[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
352Levodopa/carbidopa 100/25[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
353Levodopa/Carbidopa Hydrate[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
354Levodopa/Carbidopa Solution[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
355Levodopa/Carbidopa(200mg/50mg)[2] Carbidopa,
Levodopa
[2] D00059 ,
D00558
[6] DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[16] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
356Levodopa/carbidopa/entacapone[3] Carbidopa,
Entacapone,
Levodopa
[3] D00059 ,
D00558 ,
D00781
[7] COMT,
DDC,
DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Phenylalanine metabolism, Rap1 signaling pathway, Serotonergic synapse, Steroid hormone biosynthesis, Tryptophan metabolism, Tyrosine metabolism, cAMP signaling pathway 💬[1] 6
357Levodopa/DDCI[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
358Levodopa/dopa decarboxylase inhibitor[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
359Levofloxacin[1] Levofloxacin[2] D00588 ,
D08120
--[4] 46, 53, 84, 299
360LEVOFLOXACIN HEMIHYDRATE[1] Levofloxacin[2] D00588 ,
D08120
--[1] 299
361Levofloxacin Kabi[1] Levofloxacin[2] D00588 ,
D08120
--[1] 299
362Levofolene[1] Levoleucovorin---[1] 13
363LEVOFOLENE 4 MG 30 CPR[1] Levoleucovorin---[1] 13
364Levoketoconazole[1] Levoketoconazole[1] D10950 --[1] 75
365Levoketozonazole----[1] 75
366LEVONORGESTREL[1] Levonorgestrel[1] D00950 [1] PGR 💬[5] Breast cancer, Chemical carcinogenesis - receptor activation, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 💬[1] 13
367LEVOSIMENDAN[1] Levosimendan[1] D04720 [2] PDE3A,
PDE3B 💬
[11] Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 2
368Levothyroxine[1] Levothyroxine[2] D01010 ,
D08125
[2] THRA,
THRB 💬
[2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬[3] 49, 78, 80
369Levulan----[1] 34
370Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 1[1] Aminolevulinic acid[2] D02908 ,
D07567
--[1] 34
371Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 2[1] Aminolevulinic acid[2] D02908 ,
D07567
--[1] 34
372Levulan (5-aminolevulinic acid) photodynamic therapy - Dose level 3[1] Aminolevulinic acid[2] D02908 ,
D07567
--[1] 34
373LFB-IgSC----[1] 65
374LFB-R603----[1] 13
375LFB-R603, TGTX1101----[1] 13
376LFG316----[1] 62
377Liatermin[1] Liatermin[1] D04727 --[1] 6
378Liatermin (r-metHuGDNF)[1] Liatermin[1] D04727 --[1] 6
379LIB003----[1] 79
380Liberase Enzyme (Roche)----[2] 85, 229
381Licorice[1] Licorice[1] D04365 --[1] 53
382Lidocaine[1] Lidocaine[3] D00358 ,
D02086 ,
D08127
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[12] 6, 13, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256
383Lidocaine 1% Injectable Solution[1] Lidocaine[3] D00358 ,
D02086 ,
D08127
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 34
384Lidocaine 2% without vessel constrictor[1] Lidocaine[3] D00358 ,
D02086 ,
D08127
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 51
385Lidocaine Hydrochloride, Injectable[1] Lidocaine[3] D00358 ,
D02086 ,
D08127
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 70
386Lidocaine Injection 2%[1] Lidocaine[3] D00358 ,
D02086 ,
D08127
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 168
387Lidocaine patch 5%[1] Lidocaine[3] D00358 ,
D02086 ,
D08127
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 13
388Lidocaine Releasing Intravesical System - LiRIS®[1] Lidocaine[3] D00358 ,
D02086 ,
D08127
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 226
389Light box ( Litebook company)----[1] 6
390Light box (Litebook company)----[1] 6
391Lignocaine[1] Lidocaine[3] D00358 ,
D02086 ,
D08127
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 84
392Limaprost[1] Limaprost[1] D02722 [1] PTGER1 💬[4] Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬[1] 70
393LimphoStat-B----[1] 53
394Linaclotide[1] Linaclotide[1] D09355 [1] GUCY2C 💬[2] Metabolic pathways, Purine metabolism 💬[2] 6, 97
395Linerixibat----[1] 93
396Linerixibat (GSK2330672) 40 mg----[1] 93
397Linerixibat (GSK2330672) 45 mg----[1] 93
398Linerixibat (GSK2330672) 45mg----[1] 93
399Linez----[1] 299
400LINEZOLID[1] Linezolid[1] D00947 --[1] 299
401Lingzhi (Ganoderma)----[1] 6
402Lingzhi and Sen Miao San----[1] 46
403Linoleic acid[1] Linoleic acid---[4] 2, 5, 13, 299
404Linoleic acid supplementation[1] Linoleic acid---[1] 299
405Linoleic Acid/Oleic Acid[2] Linoleic acid,
Oleic Acid
[1] D02315 --[1] 13
406Linolenic acid[2] Gamolenic acid,
alpha-Linolenic acid
[1] D07213 --[1] 46
407LINQ device - implantable cardiac monitor - referred to in the application as implantable loop recorder or ILR)[1] Methamidophos---[1] 28
408Linsitinib[1] Linsitinib[1] D09925 [1] IGF1R 💬[29] AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, HIF-1 signaling pathway, Hepatocellular carcinoma, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 💬[1] 232
409Liofen XL----[1] 13
410LIORESAL*50CPR 10MG[1] Baclofen[1] D00241 [2] GABBR1,
GABBR2 💬
[7] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬[1] 2
411Liothyronine[1] Liothyronine[2] D01011 ,
D08128
[2] THRA,
THRB 💬
[2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬[3] 13, 210, 212
412Liothyronine I 131[2] Liothyronine,
Liothyronine I-131
[2] D01011 ,
D08128
[2] THRA,
THRB 💬
[2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬[2] 210, 212
413Liothyronine sodium[1] Liothyronine[2] D01011 ,
D08128
[2] THRA,
THRB 💬
[2] Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway 💬[1] 13
414LIPASA----[1] 299
415Lipasa ácida lisosómica, esterasa, colesterol (gen humano LIPA), lipasa ácida lisosómica (gen humano LIPA)----[1] 19
416LIPASE----[2] 298, 299
417Lipase CLEC----[1] 299
418LIPASE LIP2----[1] 299
419Lipase Lip2 from Yarrowia lipolytica----[1] 299
420Lipid-lowering agents (Artovastatin)----[1] 50
421Lipiodol[1] Ethiodized oil[2] D04082 ,
D04083
--[1] 280
422Lipiodol® Ultra Fluid with surgical glues[1] Ethiodized oil[2] D04082 ,
D04083
--[1] 280
423Lipitor[1] Atorvastatin[3] D00258 ,
D00887 ,
D07474
[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[3] 51, 96, 299
424Lipitor®----[2] 46, 53
425Lipoic acid[1] Lipoic acid[2] D00048 ,
D00086
--[5] 2, 5, 13, 14, 20
426Lipoic acid (LA) with fish oil and LA without fish oil[2] Fish oil,
Lipoic acid
[2] D00048 ,
D00086
--[1] 13
427Lipoic acid and omega-3 fatty acids[2] Lipoic acid,
Omega-3 fatty acids
[2] D00048 ,
D00086
--[1] 13
428Lipoic acid group[1] Lipoic acid[2] D00048 ,
D00086
--[1] 2
429Lipopolysaccharide----[1] 6
430Liposic----[1] 53
431Liposomal aerosol cyclosporine[1] Cyclosporine[1] D00184 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 228
432Liposomal Amikacin[1] Amikacin[2] D00865 ,
D02543
--[1] 299
433Liposomal Amikacin (Arikace TM)[1] Amikacin[2] D00865 ,
D02543
--[1] 299
434Liposomal Amikacin (Arikace™)[1] Amikacin[2] D00865 ,
D02543
--[1] 299
435Liposomal amikacin for inhalation[1] Amikacin[2] D00865 ,
D02543
--[1] 299
436Liposomal amikacin for inhalation (Arikayce™) using the PARI Investigational eFlow® Nebulizer.[1] Amikacin[2] D00865 ,
D02543
--[1] 299
437Liposomal amphotericin B (Ambisome®)[1] Amphotericin B[1] D00203 --[1] 299
438Liposomal bupivacaine[1] Bupivacaine[2] D01450 ,
D07552
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[3] 51, 70, 96
439Liposomal Cyclosporine A[1] Cyclosporine[1] D00184 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 228
440Liposomal Cyclosporine A 10 mg[1] Cyclosporine[1] D00184 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 228
441Liposomal Cyclosporine A 5 mg[1] Cyclosporine[1] D00184 [5] PPP3CA,
PPP3CB,
PPP3CC,
PPP3R1,
PPP3R2 💬
[33] Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬[1] 228
442Liposomal Doxorubicin[1] Doxorubicin[1] D03899 [2] TOP2A,
TOP2B 💬
[1] Platinum drug resistance 💬[1] 331
443Liposomal T4N5 lotion----[1] 159
444Liposome encapsulated BoNT-A----[1] 226
445Liposomed polyphenols resveratrol and curcumin[2] Curcumin,
Resveratrol
---[1] 2
446Liposomes----[1] 226
447LIPOSORBER® LA-15----[1] 222
448LIPOSORBER® LA-15 System----[1] 222
449Lipoxygenase inhibitor----[1] 160
450Liprotamasa----[1] 299
451Liprotamase----[2] 298, 299
452Liprotamase Powder for Oral Solution----[1] 299
453Lipuro----[1] 6
454LIQ861 100 µg----[1] 86
455LIQ861 106 µg----[1] 86
456LIQ861 25 µg----[1] 86
457LIQ861 26.5 µg----[1] 86
458LIQ861 50 µg----[1] 86
459LIQ861 53 µg----[1] 86
460LIQ861 75 µg----[1] 86
461LIQ861 79.5 µg----[1] 86
462LIQ861 Inhaled Treprostinil[1] Treprostinil[1] D06213 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
463Liqourice----[1] 75
464Liquigen MCT oil----[1] 6
465Liquorice[1] Licorice[1] D04365 --[1] 83
466Liraglutide[1] Liraglutide[1] D06404 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 6, 75, 193
467Lirentelimab[1] Lirentelimab[1] D11906 [1] SIGLEC8 💬-[1] 98
468Lirentelimab (AK002)[1] Lirentelimab[1] D11906 [1] SIGLEC8 💬-[1] 98
469LiRIS 400 mg----[1] 226
470LiRIS low dose and LiRIS high dose----[1] 226
471LiRIS®----[1] 226
472LiRIS® 400 mg----[1] 226
473Lisdexamfetamine[1] Lisdexamfetamine[1] D08130 [2] SLC6A2,
SLC6A3 💬
[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13
474Lisdexamfetamine sulfate[2] Lisdexamfetamine,
Sulfate ion
[1] D08130 [2] SLC6A2,
SLC6A3 💬
[7] Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬[1] 13
475Lisinopril[1] Lisinopril[2] D00362 ,
D08131
[1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[7] 19, 46, 49, 66, 67, 113, 222
476Lisinopril Pills[1] Lisinopril[2] D00362 ,
D08131
[1] ACE 💬[6] Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬[1] 49
477Lisinopril, losartan, and atorvastatin[3] Atorvastatin,
Lisinopril,
Losartan
[7] D00258 ,
D00357 ,
D00362 ,
D00887 ,
D07474 ,
D08131 ,
D08146
[3] ACE,
AGTR1,
HMGCR 💬
[22] AGE-RAGE signaling pathway in diabetic complications, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Bile secretion, Calcium signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Metabolic pathways, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Terpenoid backbone biosynthesis, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 222
478Lisparin----[1] 6
479Listed for each disorder below, up to three drugs per disorder (too many characters to list in this field----[1] 13
480LISURIDE[1] Lisuride[2] D01462 ,
D08132
[3] DRD2,
DRD3,
DRD4 💬
[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[2] 6, 86
481Lisuride Hydrogenmaleate[1] Lisuride[2] D01462 ,
D08132
[3] DRD2,
DRD3,
DRD4 💬
[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
482Lisuride Transdermal System[1] Lisuride[2] D01462 ,
D08132
[3] DRD2,
DRD3,
DRD4 💬
[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
483Lisuride TTS[1] Lisuride[2] D01462 ,
D08132
[3] DRD2,
DRD3,
DRD4 💬
[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
484Lisuride TTS 10cm²[1] Lisuride[2] D01462 ,
D08132
[3] DRD2,
DRD3,
DRD4 💬
[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
485Lisuride TTS 20cm²[1] Lisuride[2] D01462 ,
D08132
[3] DRD2,
DRD3,
DRD4 💬
[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
486Lithium[1] Lithium citrate[1] D04749 --[5] 2, 5, 6, 7, 8
487Lithium Apogepha[1] Lithium citrate[1] D04749 --[1] 2
488LITHIUM CARBONATE[2] Carbonate ion,
Lithium carbonate
[1] D00801 --[6] 2, 13, 17, 18, 19, 127
489LITHIUM CITRATE[2] Lithium carbonate,
Lithium citrate
[2] D00801 ,
D04749
--[1] 2
490Lithium Gluconate (drug) Glyceryl Triacetate GTA (drug)[1] Triacetin[1] D00384 --[1] 307
491Lithiumcarbonaat----[1] 2
492Lithiumcarbonaat 400 PCH tabletten----[1] 2
493LITIO CARBONATO----[2] 2, 17
494LIV-GAMMA SN Inj.----[1] 63
495Live Combined Bifidobacterium,Lactobacillus and Enterococcus Capsules[1] Lactobacillus delbrueckii bulgaricus---[1] 6
496Live Hookworm Larvae----[1] 13
497Live Necator americanus larvae----[1] 13
498Liver biopsy----[4] 93, 171, 231, 240
499Liver transplantation----[1] 94
500Livoletide[1] Livoletide---[1] 193
501LIXACOL----[1] 97
502Lixisenatide[1] Lixisenatide[1] D09729 [1] GLP1R 💬[3] Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 6
503Lixivaptan[1] Lixivaptan[1] D04752 [1] AVPR2 💬[3] Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67
504LJN452----[1] 93
505LJN452, 0,01 mg----[1] 93
506LJN452, 0,03 mg----[1] 93
507LJN452, 0,1 mg----[1] 93
508LJP 394----[1] 49
509LJP394----[1] 49
510Lloprost(Ventavis,BAYQ6252, 10 µg/mL)[1] Iloprost[1] D02721 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
511Lloprost(Ventavis,BAYQ6252, 20 µg/mL)[1] Iloprost[1] D02721 [1] PTGIR 💬[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬[1] 86
512LMI070----[2] 3, 8
513LMTM----[1] 127
514LMTM/TRx0237----[1] 127
515LMWH/Rivaroxaban[1] Rivaroxaban[1] D07086 [1] F10 💬[1] Complement and coagulation cascades 💬[1] 75
516LMX 4 Topical Cream----[1] 256
517LNP023----[5] 61, 62, 66, 109, 222
518LNP023 HYDROCHLORIDE SALT----[1] 62
519LNP1955----[1] 46
520Lo-Ovral Oral Contraceptive Pills----[1] 60
521LO2A eye drops----[1] 53
522LO4AB04----[1] 46
523Lobivon----[1] 167
524LOBIVON*28CPR 5MG----[1] 167
525Local Anesthesia (lidocaine hydrochloride)[1] Lidocaine[3] D00358 ,
D02086 ,
D08127
[5] SCN1A,
SCN2A,
SCN3A,
SCN5A,
SCN9A 💬
[3] Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 💬[1] 6
526Local Trade Name, 2mg----[1] 6
527Local Trade Name, 4mg----[1] 6
528Local Trade Name, 8mg----[1] 6
529Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI)----[1] 13
530LODALÈS®----[1] 6
531Lodosyn----[1] 13
532Lodotra----[1] 41
533Lodotra (delayed release prednisolone)[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 41
534Lodotra®----[1] 46
535Loestrin (norethindrone acetate and ethinyl estradiol)[4] Acetate,
Estradiol,
Ethinylestradiol,
Norethisterone
[11] D00105 ,
D00182 ,
D00554 ,
D00953 ,
D01413 ,
D01617 ,
D01953 ,
D04061 ,
D04063 ,
D04064 ,
D04065
[3] ESR1,
ESR2,
PGR 💬
[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[1] 299
536Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol)[4] Acetate,
Estradiol,
Ethinylestradiol,
Norethisterone
[11] D00105 ,
D00182 ,
D00554 ,
D00953 ,
D01413 ,
D01617 ,
D01953 ,
D04061 ,
D04063 ,
D04064 ,
D04065
[3] ESR1,
ESR2,
PGR 💬
[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[2] 46, 49
537Lojuxta[1] Lomitapide[1] D09637 [1] MTTP 💬[1] Fat digestion and absorption 💬[1] 79
538Lojuxta 10 mg hard capsules[1] Lomitapide[1] D09637 [1] MTTP 💬[1] Fat digestion and absorption 💬[1] 79
539Lojuxta 20 mg hard capsules[1] Lomitapide[1] D09637 [1] MTTP 💬[1] Fat digestion and absorption 💬[1] 79
540Lojuxta 5 mg hard capsules[1] Lomitapide[1] D09637 [1] MTTP 💬[1] Fat digestion and absorption 💬[1] 79
541Lokomat training----[1] 13
542Lomecel-B medicinal signaling cells----[1] 211
543LOMITAPIDE[1] Lomitapide[1] D09637 [1] MTTP 💬[1] Fat digestion and absorption 💬[1] 79
544Lomitapide 2mg hard capsules[1] Lomitapide[1] D09637 [1] MTTP 💬[1] Fat digestion and absorption 💬[1] 79
545Lonafarnib[1] Lonafarnib[1] D04768 [2] FNTA,
FNTB 💬
[1] Terpenoid backbone biosynthesis 💬[2] 113, 333
546Lonafarnib, Zoledronic Acid, and Pravastatin[3] Lonafarnib,
Pravastatin,
Zoledronic acid
[7] D00893 ,
D01968 ,
D04768 ,
D06378 ,
D06379 ,
D08410 ,
D08689
[4] FDPS,
FNTA,
FNTB,
HMGCR 💬
[6] AMPK signaling pathway, Bile secretion, Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 333
547LONAPEGSOMATROPIN[1] Lonapegsomatropin[1] D11486 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
548Lonapegsomatropin drug product[1] Lonapegsomatropin[1] D11486 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
549Long term follow up in all patients who received SAR422459 in previous study TDU13583----[1] 301
550Long Term Follow-Up----[1] 169
551Long term oxygen therapy[1] Oxygen[1] D00003 --[1] 88
552Long-Acting Growth Hormone (LAGH)[1] Somatotropin[1] D02691 [1] GHR 💬[5] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 78
553Long-acting somatostatin[1] Somatostatin[1] D07431 [5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬
[4] Gastric acid secretion, Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 67
554Long-chain n-3 PUFA----[1] 46
555Long-circulating liposomal prednisolone[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 46
556Longeveron Mesenchymal Stem Cells----[1] 211
557Lonodelestat----[1] 299
558LONOTEN----[1] 179
559Lopace----[1] 19
560Loperamide[1] Loperamide[3] D00729 ,
D07113 ,
D08144
[3] OPRD1,
OPRK1,
OPRM1 💬
[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 13, 97
561Loperamide hydrochloride[1] Loperamide[3] D00729 ,
D07113 ,
D08144
[3] OPRD1,
OPRK1,
OPRM1 💬
[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 97
562Lopinavir[1] Lopinavir[1] D01425 --[1] 265
563Lopinavir/Ritonavir[2] Lopinavir,
Ritonavir
[2] D00427 ,
D01425
--[1] 265
564Lopinavir/ritonavir + nevirapine[3] Lopinavir,
Nevirapine,
Ritonavir
[3] D00427 ,
D00435 ,
D01425
--[1] 265
565Lopinavir/ritonavir + zidovudine + lamivudine[4] Lamivudine,
Lopinavir,
Ritonavir,
Zidovudine
[4] D00353 ,
D00413 ,
D00427 ,
D01425
--[1] 265
566Loratadina[1] Loratadine[1] D00364 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 89
567Loratadina Stada[1] Loratadine[1] D00364 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 89
568Loratadina STADA 10 mg[1] Loratadine[1] D00364 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[1] 89
569Loratadine[1] Loratadine[1] D00364 [1] HRH1 💬[3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction 💬[4] 13, 46, 89, 98
570Lorazepam[1] Lorazepam[1] D00365 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬
[7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[2] 36, 231
571Lorcaserin[1] Lorcaserin---[1] 140
572Lorenzo's Oil----[1] 20
573Lortaan----[1] 167
574LORTAAN*28CPR RIV DIV 50MG----[1] 167
575Losartan[1] Losartan[2] D00357 ,
D08146
[1] AGTR1 💬[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[18] 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
576Losartan and Atenolol or Propranolol[3] Atenolol,
Losartan,
Propranolol
[5] D00235 ,
D00357 ,
D00483 ,
D08146 ,
D08443
[4] ADRB1,
ADRB2,
ADRB3,
AGTR1 💬
[23] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 167
577Losartan and nebivolol[2] Losartan,
Nebivolol
[3] D00357 ,
D05127 ,
D08146
[2] ADRB1,
AGTR1 💬
[22] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Renin-angiotensin system, Salivary secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬[1] 167
578Losartan and other angiotensin receptor blockers[2] Angiotensin II,
Losartan
[4] D00150 ,
D00357 ,
D02014 ,
D08146
[2] AGTR1,
AGTR2 💬
[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 19
579Losartan Bluefish 50 mg[2] Bluefish,
Losartan
[2] D00357 ,
D08146
[1] AGTR1 💬[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 58
580Losartan HEXAL[1] Losartan[2] D00357 ,
D08146
[1] AGTR1 💬[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 36
581LOSARTAN POTASICO[1] Losartan[2] D00357 ,
D08146
[1] AGTR1 💬[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 179
582LOSARTAN POTASSIUM[2] Losartan,
Potassium
[3] D00357 ,
D08146 ,
D08403
[1] AGTR1 💬[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[5] 36, 98, 167, 179, 215
583Losartan Tablets & QingReMoShen Granule[1] Losartan[2] D00357 ,
D08146
[1] AGTR1 💬[16] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬[1] 222
584Losec[1] Omeprazole[4] D00455 ,
D01207 ,
D05259 ,
D05261
[2] ATP4A,
ATP4B 💬
[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[3] 46, 225, 294
585Losec Capsules 20 mg[1] Omeprazole[4] D00455 ,
D01207 ,
D05259 ,
D05261
[2] ATP4A,
ATP4B 💬
[4] Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬[1] 46
586LOSMAPIMOD[1] Losmapimod[1] D09639 [4] MAPK11,
MAPK12,
MAPK13,
MAPK14 💬
[62] AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Alcoholic liver disease, Amyotrophic lateral sclerosis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Dopaminergic synapse, Endocrine resistance, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hepatitis B, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, IL-17 signaling pathway, Inflammatory mediator regulation of TRP channels, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Leukocyte transendothelial migration, Lipid and atherosclerosis, MAPK signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Oocyte meiosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Platelet activation, Prion disease, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rap1 signaling pathway, Relaxin signaling pathway, Retrograde endocannabinoid signaling, Salmonella infection, Shigellosis, Signaling pathways regulating pluripotency of stem cells, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thermogenesis, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, VEGF signaling pathway, Yersinia infection 💬[2] 113, 222
587LOU064----[2] 13, 53
588Lovastatin[1] Lovastatin[1] D00359 [1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[11] 6, 34, 46, 79, 156, 160, 195, 206, 263, 280, 310
589Lovastatin 60 MG[1] Lovastatin[1] D00359 [1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 34
590Lovastatin ™[1] Lovastatin[1] D00359 [1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 34
591Lovastatin, then Minocycline/Lovastatin[2] Lovastatin,
Minocycline
[3] D00359 ,
D00850 ,
D05045
[1] HMGCR 💬[4] AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬[1] 206
592Low antigen content diet----[1] 66
593Low calorie protein substitute----[1] 240
594Low carbohydrate ketogenic diet----[1] 256
595Low copper diet[1] Copper---[1] 171
596Low Dietary Sodium----[1] 49
597Low dose----[1] 97
598Low dose AFFITOPE® PD03A + Adjuvant----[1] 6
599Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day[1] Vitamin D---[1] 13
600Low Dose Aspirin (162 mg/day)[1] Acetylsalicylic acid[1] D00109 [2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 13
601Low dose BIBF 1120 twice daily----[1] 85
602Low dose BIBF1120 once daily----[1] 85
603Low Dose Budesonide[1] Budesonide[1] D00246 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 97
604Low dose budesonide tablet[1] Budesonide[1] D00246 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 98
605Low dose cannabis[1] Medical Cannabis---[1] 13
606Low dose levodopa[1] Levodopa[1] D00059 [5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬
[11] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
607Low Dose Mesenchymal Stem Cells (MSCs)----[1] 49
608Low Dose MT-1303----[1] 97
609Low dose naltrexone[1] Naltrexone[2] D02095 ,
D05113
[3] OPRD1,
OPRK1,
OPRM1 💬
[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[2] 96, 97
610Low dose of BIIL 284 BS tablets----[1] 46
611Low dose ORTD-1----[1] 46
612Low dose prednisolone[1] Prednisolone[8] D00472 ,
D00980 ,
D00981 ,
D00982 ,
D01239 ,
D01998 ,
D02156 ,
D03301
[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 84
613Low dose TSO----[1] 96
614Low dose vehicle control----[1] 46
615Low Dose-VIS649----[1] 66
616Low FODMAP----[1] 97
617Low immunogenic interferon-beta-1a[2] Human interferon beta,
Interferon beta-1a
[1] D04554 [2] IFNAR1,
IFNAR2 💬
[18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬[1] 13
618Low Molecular Weight Heparin Calcium Injection[2] Calcium,
Heparin
[1] D07510 [1] SERPINC1 💬[1] Complement and coagulation cascades 💬[1] 224
619Low Protein and High Fiber Diet----[1] 97
620Low Residue Diet Intervention----[1] 21
621Low serine diet[1] Serine[1] D00016 --[1] 96
622Low-dose Aldesleukin (Proleukin®)[1] Aldesleukin[1] D00748 [3] IL2RA,
IL2RB,
IL2RG 💬
[14] Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor 💬[1] 49
623Low-dose IL-2[1] Human interleukin-2---[1] 56
624Low-dose IL-2 administration[1] Human interleukin-2---[1] 96
625Low-dose naltrexone[1] Naltrexone[2] D02095 ,
D05113
[3] OPRD1,
OPRK1,
OPRM1 💬
[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬[1] 226
626Low-Dose REGN4461----[1] 265
627Low-Frequency-Only Stimulation----[1] 6
628Loxoprofen[1] Loxoprofen[1] D08149 [2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[2] 46, 271
629Loxoprofen sodium hydrogel patch[1] Loxoprofen[1] D08149 [2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
630Loxoprofen sodium tablet[1] Loxoprofen[1] D08149 [2] PTGS1,
PTGS2 💬
[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 271
631LP-08 20mg----[1] 226
632LP-08 80mg----[1] 226
633LPA1----[1] 85
634LPM3770164 sustained release tablet[1] Manganese citrate---[1] 8
635LPM3770164 sustained release tablet simulant[1] Manganese citrate---[1] 8
636LSD----[1] 271
637LT-02----[1] 97
638LT-02 (modified-release PC pellets)[1] Manganese citrate---[1] 97
639LT4----[1] 222
640LTP001----[1] 86
641LTS 0.25mg----[1] 46
642LTS 0.5mg----[1] 46
643LTS 1.0mg----[1] 46
644Lu 00-800----[1] 6
645LU 70274----[1] 299
646Lu AA24493----[1] 18
647Lu AF28996----[1] 6
648Lu AF82422----[2] 6, 17
649Lu AG06466----[1] 13
650LUBIPROSTONE[1] Lubiprostone[1] D04790 [1] CLCN2 💬[1] Mineral absorption 💬[4] 6, 13, 290, 299
651Lucen----[1] 113
652Lucentis[1] Ranibizumab[1] D05697 [1] VEGFA 💬[24] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, EGFR tyrosine kinase inhibitor resistance, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬[1] 166
653Lucerastat[1] Lucerastat[1] D11439 [1] UGCG 💬[2] Metabolic pathways, Sphingolipid metabolism 💬[1] 19
654Lucinactant[1] Lucinactant[1] D04792 --[1] 299
655Lucinactant first[1] Lucinactant[1] D04792 --[1] 299
656Lucrin----[1] 67
657Lulizumab Pegol[1] Lulizumab pegol---[1] 49
658LUM----[1] 299
659LUM-201----[1] 78
660LUM/IVA----[1] 299
661LUM/IVA fixed-dose combination----[1] 299
662LUM001----[4] 93, 94, 297, 338
663LUM001 (Maralixibat)[1] Maralixibat[1] D10951 [2] SLC10A1,
SLC10A2 💬
[2] Bile secretion, Hepatitis B 💬[1] 297
664LUMACAFTOR[1] Lumacaftor[1] D10134 [1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
665Lumacaftor / ivacaftor[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
666Lumacaftor plus Ivacaftor[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
667Lumacaftor Plus Ivacaftor Combination[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
668Lumacaftor, Ivacaftor Drug Combination[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
669Lumacaftor-ivacaftor[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
670Lumacaftor-Ivacaftor treatment[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
671Lumacaftor/Ivacaftor[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
672Lumacaftor/ivacaftor 100mg/125mg tablets[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
673Lumacaftor/ivacaftor 200mg/125mg[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
674Lumacaftor/ivacaftor 200mg/125mg tablets[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
675Lumacaftor/ivacaftor 200mg/83mg tablet[2] Ivacaftor,
Lumacaftor
[2] D09916 ,
D10134
[1] CFTR 💬[8] ABC transporters, AMPK signaling pathway, Bile secretion, Gastric acid secretion, Pancreatic secretion, Tight junction, Vibrio cholerae infection, cAMP signaling pathway 💬[1] 299
676LUMASIRAN[1] Lumasiran[1] D11925 [1] HAO1 💬[4] Carbon metabolism, Glyoxylate and dicarboxylate metabolism, Metabolic pathways, Peroxisome 💬[1] 234
677Lumbar epidural injection----[1] 70
678Lumbar Interbody Fusion with Autograft[1] Iron polymaltose---[1] 70
679Lumbar Interbody Fusion with NeoFuse[1] Iron polymaltose---[1] 70
680Lumbar interlaminar epidural steroid injection----[1] 70
681Lumbar Puncture----[6] 6, 13, 19, 96, 97, 127
682Lumentin 44----[1] 96
683Lumiracoxib[1] Lumiracoxib[1] D03714 [1] PTGS2 💬[22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[1] 46
684Lumizyme[1] Alglucosidase alfa[1] D03207 [1] GAA 💬[4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬[1] 256
685Lumizyme®[1] Alglucosidase alfa[1] D03207 [1] GAA 💬[4] Galactose metabolism, Lysosome, Metabolic pathways, Starch and sucrose metabolism 💬[1] 256
686Lunasin[1] Lunasine---[1] 2
687Lunasin Regimen[1] Lunasine---[1] 2
688Lung Clearance Index----[1] 299
689Lung Spheroid Stem Cells 100 million----[1] 85
690Lung Spheroid Stem Cells 200 million----[1] 85
691Lung stem cells----[1] 85
692Luo-Fu-Shan Plaster----[1] 46
693Luphere depot 3.75mg(Leuprolide acetate 3.75mg)[2] Acetate,
Leuprolide
[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 76
694Lupron (leuprolide acetate)[2] Acetate,
Leuprolide
[1] D00989 [1] GNRHR 💬[2] GnRH signaling pathway, Neuroactive ligand-receptor interaction 💬[1] 76
695Lupuzor----[1] 49
696Lusvertikimab----[1] 97
697Lutein[1] Lutein---[3] 13, 90, 164
698Lutein (10 or 30 mg/day) capsules[1] Lutein---[1] 90
699Lutein plus Zeaxanthin[2] Lutein,
Zeaxanthin
---[1] 164
700Luteinizing hormone[1] Luteinizing hormone---[1] 254
701Luteinizing hormone-releasing factor[1] Luteinizing hormone---[1] 254
702LUTENYL----[1] 13
703LX1606----[1] 97
704LX3305----[2] 46, 161
705LX3305 250 mg capsule----[1] 161
706LX3305 Dihydrate----[1] 46
707LX3305 high dose----[1] 46
708LX3305 low dose----[1] 46
709LX3305 mid dose----[1] 46
710LY03003----[1] 6
711LY03003 ( Rotigotine, extended-release microspheres)[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
712LY03003 (rotigotine extended release microspheres for intramuscular [IM] injection)[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
713LY03003( the name of rotigotine)[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
714LY03003(Rotigotine,extended-release microspheres)[1] Rotigotine[1] D05768 [1] DRD2 💬[8] Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 6
715LY03009 F1----[1] 6
716LY03009 F2----[1] 6
717LY03009 F3----[1] 6
718LY03009 F4----[1] 6
719LY2127399----[3] 13, 46, 49
720LY2127399 (Tabalumab)[1] Tabalumab[1] D10083 [1] TNFSF13B 💬[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 46
721LY2189102----[1] 46
722LY2439821----[3] 46, 107, 271
723LY248686----[1] 13
724LY300164----[1] 6
725LY3009104----[6] 46, 49, 50, 93, 107, 325
726LY3074828----[3] 37, 96, 97
727LY3090106----[1] 53
728LY3090106 - IV----[1] 46
729LY3090106 - SQ----[1] 46
730LY3154207----[1] 6
731LY3337641----[1] 46
732LY3337641 20 mg----[1] 46
733LY3337641 5 mg----[1] 46
734LY3361237----[1] 49
735LY3462817----[1] 46
736LY3471851----[2] 49, 97
737LY450190----[1] 86
738LYC-30937----[1] 97
739LYC-30937-EC----[1] 97
740Lycium Barbarum----[1] 90
741Lym-X-Sorb powder----[1] 299
742Lymphocyte immune globulin----[1] 96
743Lymphoseek[1] Tilmanocept---[1] 46
744LymphoStat-B----[1] 49
745LymphoStat-B TM----[1] 49
746LymphoStat-B®, monoclonal anti-BLyS, LSB, BENLYSTA®[1] Belimumab[1] D03068 [1] TNFSF13B 💬[4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬[1] 49
747Lyophilized etanercept powder(Yisaipu)[1] Etanercept[1] D00742 [2] LTA,
TNF 💬
[67] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬[1] 271
748Lyrica[1] Pregabalin[1] D02716 [4] CACNA2D1,
CACNA2D2,
CACNA2D3,
CACNA2D4 💬
[7] Adrenergic signaling in cardiomyocytes, Arrhythmogenic right ventricular cardiomyopathy, Cardiac muscle contraction, Dilated cardiomyopathy, Hypertrophic cardiomyopathy, MAPK signaling pathway, Oxytocin signaling pathway 💬[1] 298
749Lyrica®----[1] 298
750LYS----[1] 19
751LYS-GM101----[1] 19
752LYS-SAF302----[1] 19
753LYS006----[1] 97
754Lysine[1] Lysine[1] D02304 --[4] 13, 97, 228, 299
755Lysine-D-Proline-Threonine[4] D-Proline,
Lysine,
Proline,
Threonine
[3] D00035 ,
D00041 ,
D02304
--[1] 97
756Lysodase----[1] 19
757Lysomucil 10 %----[1] 299
758Lysosomal acid lipase, Esterase cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA)[1] Cholesterol[1] D00040 --[1] 19
759Lysosomal acid lipase, Esterase, cholesterol (human gene LIPA), Lysosomal acid lipase (human gene LIPA)[1] Cholesterol[1] D00040 --[1] 19
760LZRSE-Col7A1 Engineered Autologous Epidermal Sheets----[1] 36